|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.36 USD | -0.26% |
|
-0.97% | +72.09% |
| 13/11 | Alignment Healthcare Insider Sold Shares Worth $2,936,772, According to a Recent SEC Filing | MT |
| 31/10 | UBS Adjusts Alignment Healthcare Price Target to $18 From $17, Maintains Neutral Rating | MT |
| Capitalization | 387.38Cr 330.01Cr 308.26Cr 290.04Cr 533.98Cr 35TCr 583.35Cr 3.6TCr 1.4TCr 17TCr 1.45TCr 1.42TCr 60TCr | P/E ratio 2025 * |
-179x | P/E ratio 2026 * | 213x |
|---|---|---|---|---|---|
| Enterprise value | 361.11Cr 307.63Cr 287.36Cr 270.37Cr 497.76Cr 33TCr 543.79Cr 3.35TCr 1.3TCr 15TCr 1.35TCr 1.33TCr 56TCr | EV / Sales 2025 * |
0.92x | EV / Sales 2026 * | 0.7x |
| Free-Float |
55.92% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Alignment Healthcare, Inc.
| 1 day | -0.26% | ||
| 1 week | -0.97% | ||
| Current month | +0.78% | ||
| 1 month | +16.63% | ||
| 3 months | +20.70% | ||
| 6 months | +28.38% | ||
| Current year | +72.09% |
| 1 week | 18.76 |  | 20.05 |
| 1 month | 15.84 | | 20.05 |
| Current year | 11.3 | | 21.06 |
| 1 year | 10.18 | | 21.06 |
| 3 years | 4.46 | | 21.06 |
| 5 years | 4.46 | | 28.59 |
| 10 years | 4.46 | | 28.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Kao
CEO | Chief Executive Officer | 63 | 01/01/2014 |
James Head
DFI | Director of Finance/CFO | 60 | 02/05/2025 |
Dawn Maroney
PSD | President | 57 | 13/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
John Kao
BRD | Director/Board Member | 63 | 01/01/2014 |
David Hodgson
BRD | Director/Board Member | 68 | 01/01/2014 |
Mark McClellan
BRD | Director/Board Member | 61 | 01/01/2014 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.03% | 324 M€ | +9.21% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.26% | -0.97% | +74.10% | +61.47% | 387.38Cr | |
| +1.52% | +3.30% | -33.72% | -37.38% | 31TCr | |
| -0.32% | +8.56% | -5.11% | -32.78% | 7.98TCr | |
| +0.90% | +3.49% | -2.92% | -19.04% | 7.34TCr | |
| +0.74% | +4.11% | -1.59% | -49.35% | 3.23TCr | |
| +0.96% | +6.55% | -29.57% | -52.99% | 2.01TCr | |
| +0.96% | +10.96% | -43.30% | -52.27% | 866.09Cr | |
| +2.69% | +11.20% | +79.74% | -14.42% | 230.27Cr | |
| -1.82% | +4.65% | -10.00% | +143.24% | 139.5Cr | |
| -2.25% | -0.17% | -22.99% | - | 39Cr | |
| Average | -0.13% | +5.17% | +0.47% | -5.95% | 5.32TCr | |
| Weighted average by Cap. | +0.02% | +4.42% | -21.88% | -34.42% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 393.96Cr 335.62Cr 313.5Cr 294.97Cr 543.06Cr 36TCr 593.27Cr 3.66TCr 1.42TCr 17TCr 1.48TCr 1.45TCr 61TCr | 512.53Cr 436.62Cr 407.86Cr 383.74Cr 706.49Cr 46TCr 771.82Cr 4.76TCr 1.85TCr 22TCr 1.92TCr 1.88TCr 80TCr |
| Net income | -2.46Cr -2.1Cr -1.96Cr -1.84Cr -3.39Cr -222.84Cr -3.7Cr -23Cr -8.86Cr -105.04Cr -9.23Cr -9.04Cr -383.23Cr | 2.01Cr 1.72Cr 1.6Cr 1.51Cr 2.78Cr 182.44Cr 3.03Cr 19Cr 7.26Cr 86Cr 7.56Cr 7.4Cr 313.75Cr |
| Net Debt | -26Cr -22Cr -21Cr -20Cr -36Cr -2.38TCr -40Cr -244.02Cr -95Cr -1.12TCr -99Cr -96Cr -4.09TCr | -30Cr -26Cr -24Cr -23Cr -42Cr -2.74TCr -46Cr -280.87Cr -108.95Cr -1.29TCr -113.46Cr -111.07Cr -4.71TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/25/12 | 19.36 $ | -0.26% | 29,15,735 |
| 11/25/11 | 19.41 $ | +2.64% | 48,67,873 |
| 10/25/10 | 18.91 $ | -1.56% | 20,94,708 |
| 09/25/09 | 19.21 $ | -0.77% | 15,30,371 |
| 08/25/08 | 19.36 $ | -0.97% | 25,47,872 |
Delayed Quote Nasdaq, December 13, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition